World Histone Deacetylase Inhibitors Market

Date: 2016-08

Increasing cancer incidences, ongoing research and development on HDAC inhibitors for the treatment of cancer and other diseases, and the potential of HDAC inhibitors to improve the effectiveness of new therapies are the major market drivers for this market. Increasing collaborations and huge investments will ensure significant growth opportunities in the near future. In fact, the parent epigenetics market is expected to grow at a CAGR of around 30% worldwide from 2013 to 2020. On the other hand, reimbursement and uncertainty issues may serve as market restraints.


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample